Healthcare

China Health Announces US$10.1 Million Sales Order for Its Food Safety Business

China Health Labs & Diagnostics Ltd., a TSX Venture-listed company, announced that it has secured a sales order of US$10.1 million from the Beijing municipal government for food safety testing

Information summarized from:  China Health Labs & Diagnostics Ltd. Press Release

Urodynamix Enters into Agreement for Sale of NIRS Business to Chinese Biotech Company

Vancouver-based Urodynamix Technologies Ltd. announced that it has signed a definitive agreement with HEGLN (Dalian) Pharmaceutical Co. Ltd.

Information summarized from:  Urodynamix Technologies Ltd. Press Release

IDC to Supply Imaging Technology to 600 Rural and Remote Counties in China

Calgary-based IDC (Imaging Dynamics Company Ltd.) announced it has been awarded a contract by the China Foundation for Poverty Alleviation (CFPA) to supply 600 rural and remote counties in China wi

Information summarized from:  Imaging Dynamics Company Press Release

Labopharm Completes Licensing and Distribution Agreement with Nippon Shinyaku for Once-daily Tramadol in Japan

Quebec-based Labopharm Inc.

Information summarized from:  Labopharm Inc. Press Release

Pacgen Biopharmaceuticals Signs Research Collaboration Agreements in China

Vancouver-based Pacgen Biopharmaceuticals Corporation announced that it has signed agreements for research and development (R&D) collaboration with Shanghai-based New Summit Biopharma Co., a pr

Information summarized from:  Marketwire

Pharmaxis Ltd. of Australia to Acquire Topigen Pharmaceuticals Inc.

Pharmaxis Ltd. of Sydney, Australia announced an agreement to acquire Montreal-based biopharmaceutical company Topigen Pharmaceuticals Inc.

Information summarized from:  Pharmaxis Ltd. Press Release

Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst in South Korea

London, Ontario-based Stellar Pharmaceuticals Inc., a Canadian pharmaceutical developer and marketer of products for select health care markets, announced that it has signed a licensing agreement with Jeilmedix Pharmaceutical Co., a South Korean importer and distributor specializing in pharmaceutical products and medical devices. The agreement concerns the sale and distribution of Uracyst, a sterile sodium chondroitin sulfate solution (2%) for the treatment of interstitial cystitis/painful bladder syndrome in South Korea.

Information summarized from:  Stellar Pharmaceuticals Inc. Press Release

Noveko Signs a 3-Year Distribution Agreement for Antimicrobial Masks in Malaysia, Singapore, Indonesia, Thailand and Brunei

Montreal-based Noveko International Inc. announced that its subsidiary, Noveko Inc., concluded an exclusive distribution agreement for its antimicrobial masks and respirators and its Azuro hand sanitizers with Malaysian-based SappTech Sdn. Bhd. This agreement, which has an initial term of three years, covers the distribution of these products in Malaysia, Singapore, Indonesia, Thailand and Brunei Darussalam. The agreement also covers Epurair Inc. air purifiers.

Information summarized from:  Noveko International Inc. Press Release

Imaging Dynamics Company Awarded Contracts with Three Hospitals in India

Calgary-based Imaging Dynamics Company Ltd. announced that it was awarded three separate contracts by hospitals in Mumbai, India- King Edward Memorial Hospital, Lokmanya Tilak Muncipal General Hospital and BYL Nair Charitable Hospital - to supply its X-Series 1590 digital radiography (DR) systems and Magellan software. The systems were shipped in the second quarter of 2009 and installations are expected to be completed by the end of the year. CURA Medical Equipment Pvt.

Information summarized from:  Imaging Dynamics Company Press Release

Medicago Inc. Signs MOU with Ajanta Pharma for Commercial Development of Influenza Vaccines in India

Quebec City-based Medicago Inc., a biotechnology company focused on developing vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announced that it has signed a Memorandum of Understanding (MOU) with Ajanta Pharma Limited to discuss and negotiate an agreement to commercialize Medicago’s pandemic and seasonal influenza VLP-based vaccines in India and other territories. Ajanta has strong relationships with the Indian Government health departments, defence services and hospitals.

Information summarized from:  Medicago Inc. Press Release

Use 'AND' or 'OR' to refine your search.

Use quotes " " to get exact matches or remove them to get more results.